$9.57
0.829.37%
Last update: Nov 9, 3:26 PM
Candel Therapeutics Inc
CADLNASDAQ
The average analyst price target for Candel Therapeutics is $20.55, 114.7% above the current price. Of 10 analysts, 10 rate it Buy. Targets range from $14 to $26. The latest change came on Oct 22, 2026, when Jefferies initiated coverage of Candel Therapeutics with a Buy rating and a $25 price target.
Price Target Range — 9 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
